Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 27.71B | 28.21B | 25.89B | 22.68B | 20.10B | 18.99B |
Gross Profit | 7.44B | 7.60B | 6.28B | 5.28B | 4.84B | 5.13B |
EBITDA | 3.29B | 3.95B | 3.31B | 2.27B | 2.14B | 1.89B |
Net Income | 2.77B | 2.85B | 2.37B | 1.67B | 1.61B | 1.20B |
Balance Sheet | ||||||
Total Assets | 32.04B | 33.76B | 32.42B | 28.26B | 24.75B | 23.48B |
Cash, Cash Equivalents and Short-Term Investments | 5.31B | 6.64B | 5.27B | 4.88B | 3.80B | 3.97B |
Total Debt | 2.66B | 4.82B | 3.10B | 2.23B | 1.57B | 1.61B |
Total Liabilities | 8.31B | 9.89B | 8.57B | 6.74B | 5.03B | 5.23B |
Stockholders Equity | 23.67B | 23.83B | 23.83B | 21.45B | 19.76B | 18.37B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 3.02B | 621.73M | 305.24M | 292.81M | 1.61B |
Operating Cash Flow | 0.00 | 3.32B | 942.53M | 579.56M | 555.07M | 1.84B |
Investing Cash Flow | 0.00 | -1.49B | -517.20M | -169.59M | -476.15M | -478.72M |
Financing Cash Flow | 0.00 | -436.55M | -69.94M | 633.64M | -275.28M | -345.03M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥10.05B | 4.65 | 2.76% | 3.07% | 44.35% | ||
78 Outperform | ¥27.65B | 10.08 | 3.52% | 8.96% | 21.61% | ||
74 Outperform | ¥72.15B | 13.17 | 5.00% | 5.29% | 0.76% | ||
71 Outperform | ¥33.08B | 10.96 | 3.39% | -6.50% | 46.56% | ||
65 Neutral | £10.32B | 8.28 | 3.35% | 3.43% | -1.42% | 18.13% | |
61 Neutral | ¥95.36B | 15.54 | 4.26% | 4.69% | -25.47% |
Fuji Nihon Seito Corporation reported a significant increase in its consolidated financial results for the fiscal year ended March 31, 2025, with net sales rising by 9% and operating profit by 48.7% year-on-year. Despite a decline in comprehensive income, the company maintained strong financial health with a high equity ratio and increased cash flow from operating activities, indicating robust operational performance and a stable financial position.